Recent News

• 05.20.2026 - Immunovant Provides Corporate Updates and Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026
• 05.11.2026 - Immunovant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026, and Provide Business Update on Wednesday, May 20, 2026

Recent Filings

• 05.20.2026 - 8-K Current report
• 05.20.2026 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 05.20.2026 - EX-99.1 EX-99.1
• 05.01.2026 - 144 Report of proposed sale of securities
• 05.01.2026 - 4 Statement of changes in beneficial ownership of securities
• 04.24.2026 - 4 Statement of changes in beneficial ownership of securities
• 04.24.2026 - 4 Statement of changes in beneficial ownership of securities
• 04.10.2026 - 4 Statement of changes in beneficial ownership of securities
• 04.10.2026 - 4 Statement of changes in beneficial ownership of securities
• 04.10.2026 - 4 Statement of changes in beneficial ownership of securities